ArticleBone marrow research2011

One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133 Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction.

Samer Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.